Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
cinacalcet (sensipar) (1 trial)
Hyperparathyroidism (Phase 3)
Hyperparathyroidism, Secondary (Phase 3)
Kidney Diseases (Phase 3)
Neoplasm Metastasis (Phase 3)
Renal Insufficiency, Chronic (Phase 3)
Trials (1 total)
Trial APIs (1 total)